Cel-Sci
CVM
#9811
Rank
S$61.89 M
Marketcap
S$7.74
Share price
-5.66%
Change (1 day)
-70.55%
Change (1 year)

Earnings for Cel-Sci (CVM)

Earnings in 2025 (TTM): -S$32.58 Million

According to Cel-Sci 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -S$34.29 Million, an increase over its 2023 earnings that were of -S$39.15 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cel-Sci from 1986 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$32.58 Million-4.98%
2024 -S$34.29 Million-12.41%
2023 -S$39.15 Million-12.87%
2022 -S$44.93 Million-3.42%
2021 -S$46.52 Million13.44%
2020 -S$41.01 Million11.28%
2019 -S$36.85 Million179.81%
2018 -S$13.17 Million-48.72%
2017 -S$25.69 Million-16.23%
2016 -S$30.66 Million-23.63%
2015 -S$40.15 Million-5.47%
2014 -S$42.47 Million198.49%
2013 -S$14.23 Million
2010 -S$16.61 Million
2004 -S$5.62 Million12.38%
2003 -S$5 Million-16.59%
2002 -S$5.99 Million-59.28%
2001 -S$14.71 Million23.17%
2000 -S$11.94 Million20.12%
1999 -S$9.94 Million13.24%
1998 -S$8.78 Million-20%
1997 -S$10.97 Million46.55%
1996 -S$7.49 Million34.88%
1995 -S$5.55 Million2.38%
1994 -S$5.43 Million68%
1993 -S$3.23 Million78.57%
1992 -S$1.81 Million180%
1991 -S$0.65 Million25%
1990 -S$0.52 Million-0%
1989 -S$0.52 Million-71.43%
1988 -S$1.81 Million-0%
1987 -S$1.81 Million-46.15%
1986 -S$3.36 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Curis
CRIS
-S$42.02 Million 31.68%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-S$8.54 Million-73.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$10.63 B-33,443.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-S$0.18 Billion 458.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$2.28 B-7,266.95%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Johnson & Johnson
JNJ
S$41.80 B-131,127.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$0.21 B-768.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-S$12.25 Million-61.62%๐Ÿ‡บ๐Ÿ‡ธ USA